Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Zhejiang Orient Gene Biotech Co Days Payable?
Zhejiang Orient Gene Biotech CoSHSE:688298 -3.51%51 Days Payable is 270.64 as of Mar. 2026, which is 112% above its 10-year median of 127.53. GuruFocus rates SHSE:688298 with a GF Score™ of 51/100 and a GF Value™ of ¥30.81 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Zhejiang Orient Gene Biotech Co ranks better than 88.93% on this metric.
The historical rank and industry rank for Zhejiang Orient Gene Biotech Co's Days Payable or its related term are showing as below:
SHSE:688298'
s Days Payable Range Over the Past 10 Years
Min: 92.51 Med: 127.53 Max: 851.41
Current: 293.24
During the past 10 years, Zhejiang Orient Gene Biotech Co's highest Days Payable was 851.41. The lowest was 92.51. And the median was 127.53.
SHSE:688298's Days Payable is ranked better than 88.93% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs SHSE:688298: 293.24
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Orient Gene Biotech Co Days Payable Chart
SHSE:688298 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Zhejiang Orient Gene Biotech Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Orient Gene Biotech Co Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zhejiang Orient Gene Biotech Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Zhejiang Orient Gene Biotech Co's Days Payable falls into.
Zhejiang Orient Gene Biotech Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Orient Gene Biotech Co (SHSE:688298) has a Days Payable of 270.64 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zhejiang Orient Gene Biotech Co and its competitors. This is 112% above median its historical median of 127.53. Over the past decade, Zhejiang Orient Gene Biotech Co's Days Payable has ranged from 92.51 to 851.41. According to the industry distribution chart, Zhejiang Orient Gene Biotech Co ranks #88 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 11.1%.
Is Zhejiang Orient Gene Biotech Co's Days Payable too high?
Zhejiang Orient Gene Biotech Co's current Days Payable of 270.64 is 112% above median its 10-year median of 127.53. Over the past 10 years, this metric has ranged from a low of 92.51 to a high of 851.41. The Medical Devices & Instruments industry median Days Payable is 67.87. Zhejiang Orient Gene Biotech Co's value of 270.64 is 298.8% above this industry median. Based on the distribution chart, Zhejiang Orient Gene Biotech Co ranks #88 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Zhejiang Orient Gene Biotech Co has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Orient Gene Biotech Co's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Zhejiang Orient Gene Biotech Co ranks #88 out of 795 companies for Days Payable. This places Zhejiang Orient Gene Biotech Co in the top 11% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.87. Zhejiang Orient Gene Biotech Co's value of 270.64 is 298.8% above this benchmark. Historically, Zhejiang Orient Gene Biotech Co's own Days Payable has ranged from 92.51 to 851.41 over the past decade. While the company's 10-year median is 127.53 vs. the industry median of 67.87, Zhejiang Orient Gene Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Orient Gene Biotech Co's current Days Payable of 270.64 is 298.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zhejiang Orient Gene Biotech Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Orient Gene Biotech Co's current Days Payable is 270.64, which is 112% above median its own 10-year median of 127.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Orient Gene Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Orient Gene Biotech Co (SHSE:688298) is currently considered Possible Value Trap. The stock's GF Value™ is ¥30.81, compared to a current price of ¥17.87 — trading 42% below its estimated fair value. The current Days Payable is 270.64, which is 112% above median its 10-year median of 127.53 and 298.8% above the Medical Devices & Instruments industry median of 67.87. Zhejiang Orient Gene Biotech Co's overall GF Score™ is 51/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Zhejiang Orient Gene Biotech Co (SHSE:688298), the current Days Payable is 270.64 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhejiang Orient Gene Biotech Co (SHSE:688298) Overvalued in 2026?
Based on GuruFocus' analysis, Zhejiang Orient Gene Biotech Co stock appears to be undervalued.
The current stock price of ¥17.87 is trading 42% below its estimated GF Value™ of ¥30.81.
GuruFocus considers Zhejiang Orient Gene Biotech Co to be Possible Value Trap.
Key valuation signals for SHSE:688298:
Days Payable: 270.64 (112% above median its 10-year median of 127.53)
GF Value™: ¥30.81 vs. price of ¥17.87 (42% below fair value)
Industry Position: 298.8% above the Medical Devices & Instruments median (#88 of 795)
No single metric tells the full story. See the SHSE:688298 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhejiang Orient Gene Biotech Co Business Description
Zhejiang Orient Gene Biotech Co Ltd is engaged in production, research, development and sale of vitro diagnostic products. The company's products include Genetic diagnosis, Colloidal gold rapid diagnostic tests, Dry chemical strips (urinalysis), Bio-liquid diagnostic kits, Clinical test instruments, POCT time-resolved Fluor immunoassay Test kit (TRFI), and Raw materials.
51GF Score
Get the complete analysis for SHSE:688298
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688298 has been successfully added to your 
